S0758

Sulfaphenazole

≥98%, CYP2C9 inhibitor, powder

• Synonim(y): 4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
• Wzór empiryczny (zapis Hilla): C₁₅H₁₄N₄O₂S
• Numer CAS: 526-08-9
• Masa cząsteczkowa: 314.36
• NACRES: NA.77
• PubChem Substance ID: 24278198
• UNSPSC Code: 12352204
• EC Number: 208-384-3
• MDL number: MFCD00057226

Właściwości

• Nazwa produktu: Sulfaphenazole, ≥98%
• Quality Segment: 100
• assay: ≥98%
• form: powder
• solubility: ethanol: 25 mg/mL, clear, colorless to yellow
• storage temp.: 2-8°C
• SMILES string: Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2-c3ccccc3
• InChI: 1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2
• InChI key: QWCJHSGMANYXCW-UHFFFAOYSA-N
• Gene Information: human ... CYP2C18(1562), CYP2C19(1557), CYP2C9(1559)

Opis

Application

Sulfaphenazole has been used as a positive control to inhibit cytochrome P450 2C9 (cyp2c9) to quantify Rhodiola rosea inhibition. It has also been used as cytochrome P450 2C9 (cyp2c9) inhibitor in endothelial cells and microsomal preparations.

Biochem/physiol Actions

Antibacterial. Specific inhibitor of CYP2C9. Blocks pro-inflammatory and atherogenic effects of linoleic acid (increase in oxidative stress and activation of AP-1) mediated by CYP2C9. Specific inhibitor of CYP2C9. Blocks pro-inflammatory and atherogenic effects of linoleic acid (increase in oxidative stress and activation of AP-1) mediated by CYP2C9. Inhibits bradykinin-induced tPA release.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)